Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
4213
Reference Type
Book/Book Chapter
Title
Dose-route extrapolations in quantitative toxicology: Physiologically based pharmacokinetics and pharmacodynamics of chloroform
Author(s)
Corley, RA; Reitz, RH
Year
1990
Publisher
Elsevier
Location
New York, NY
Book Title
Principles of route to route extrapolation for risk assessment : proceedings of the workshop held in South Carolina and North Carolina
Page Numbers
195-216
Language
English
Relationship(s)
is a chapter of
4185786
Principles of route to route extrapolation for risk assessment : Proceedings of the workshop held in South Carolina and North Carolina
Abstract
Prior chapters focused on the biology of the respiratory tract, gastrointestinal tract, and skin as each related to absorption of xenobiotics. Key parameters that were considered important for describing the uptake, disposition, and toxicity were addressed. The purpose of this paper is to apply some of the principles already discussed using a physiologically based pharmacokinetic (PB-PK)/ pharmacodynamic model developed for chloroform [1, 2]. This model was developed to provide a rational basis for risk assessment by incorporating available information on the disposition and mechanisms of action of chloroform as a function of dose, species, and route of administration.
A recent risk assessment for chloroform [3] was based on a National Cancer Institute bioassay where a high incidence of liver tumors was observed in B5C3F1 mice when chloroform was administered by gavage in corn oil [4]. The significance of this study for human cancer risk assessment is questionable, especially since a recent bioassay conducted in the same strain of mice by a more appropriate route of administration (drinking water) at daily dose levels of chloroform comparable to the National Cancer Institute study resulted in no liver tumors [SJ.
Since the results from a battery of mutagenicity tests with chloroform have been largely negative [6], Reitz et a/.[7] have proposed that chloroform induces tumors in laboratory animals without direct interaction of chloroform, or its reactive metabolites, with the genome. Rather, the carcinogenicity of chloroform appears to be correlated with recurrent cytotoxicity and compensatory cell regeneration, which results from the metabolic activation of chloroform.
Editor(s)
Gerrity, TR; Henry, CJ
ISBN
9780444015822
Conference Name
Workshops on Principles of Route-to-Route Extrapolation for Risk Assessment
Conference Location
Hilton Head, SC; Durham, NC
Conference Dates
March 19-21, 1990; July 10-11, 1990
Tags
•
Chloroform Combined (current)
Chloroform (original)
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity